CASI Pharmaceuticals, Inc 20-F for FY2024
CASI Pharmaceuticals, Inc. (CASIF)
20-F
2025-03-31
For: 2024-12-31
View Original
Added on
April 12, 2026
About this 20-F
CASI Pharmaceuticals, Inc filed this 20-F on March 31, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $28.54M
- down 15.8% from $33.88M a year earlier
- Net loss
- $39.26M
- compared with a net loss of $26.96M a year earlier
- Diluted EPS
- -$2.56
- compared with -$2.02 a year earlier